◆英語タイトル:Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8013736
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月21日
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Oriola-KD Oyj (OKDBV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Oriola-KD Oyj (Oriola-KD) is a retail and wholesale company which distributes pharmaceuticals and health and wellbeing products. It offers expert advice on health and wellbeing and quality products through pharmacies. The company provides wide service offerings covering pharmaceutical distribution, branded products and other tailored services to healthcare operators. Its product portfolio includes vitamins, pharmaceutical cosmetics, skincare products, tests, dietary supplements, sports drinks, wound care products and other related products under Avene, Gefilus, Lysi and Oriola’s brands. It also provides pharmaceutical distribution services and a range of value adding services from clinical research to consumer services to pharmacies, pharma companies, veterinarians and grocery stores. Oriola-KD also maintains partnerships with other pharma companies to distribute several drugs in Finland, Sweden, Estonia, Latvia, Lithuania and Russia. Oriola-KD is headquartered in Espoo, Finland.
Oriola-KD Oyj Key Recent Developments
Oct 25,2017: Oriola: Interim Report January-September 2017
Oct 12,2017: Oriola third quarter result impacted by distribution disruptions in Finland
Jul 21,2017: Oriola’s Half Year Financial Report January-June 2017
Jul 13,2017: Oriola revises guidance for continuing operations adjusted operating profit
Jul 07,2017: Changes in Oriola’s Group Management Team
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Oriola-KD Oyj – Key Facts 5
Oriola-KD Oyj – Key Employees 6
Oriola-KD Oyj – Key Employee Biographies 7
Oriola-KD Oyj – Major Products and Services 8
Oriola-KD Oyj – History 9
Oriola-KD Oyj – Company Statement 10
Oriola-KD Oyj – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Oriola-KD Oyj – Business Description 12
Oriola-KD Oyj – Corporate Strategy 13
Oriola-KD Oyj – SWOT Analysis 14
SWOT Analysis – Overview 14
Oriola-KD Oyj – Strengths 14
Oriola-KD Oyj – Weaknesses 15
Oriola-KD Oyj – Opportunities 16
Oriola-KD Oyj – Threats 17
Oriola-KD Oyj – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Oriola-KD Oyj, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Oct 25, 2017: Oriola: Interim Report January-September 2017 29
Oct 12, 2017: Oriola third quarter result impacted by distribution disruptions in Finland 31
Jul 21, 2017: Oriola’s Half Year Financial Report January-June 2017 32
Jul 13, 2017: Oriola revises guidance for continuing operations adjusted operating profit 33
Jul 07, 2017: Changes in Oriola’s Group Management Team 34
Jun 22, 2017: Oriola has rearranged its long-term revolving credit facility and term loan agreement 35
Apr 28, 2017: Oriola Interim Report for 1 January – 31 March 2017 36
Feb 13, 2017: Oriola-KD’s Financial Statements Release 2016 39
Oct 20, 2016: Oriola-KD Interim Report for 1 January-30 September 2016 41
Sep 07, 2016: Terhi Kivinen Appointed Group Communications Director, Oriola-Kd Corporation 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47
List of Tables
Oriola-KD Oyj, Key Facts 5
Oriola-KD Oyj, Key Employees 6
Oriola-KD Oyj, Key Employee Biographies 7
Oriola-KD Oyj, Major Products and Services 8
Oriola-KD Oyj, History 9
Oriola-KD Oyj, Subsidiaries 11
Oriola-KD Oyj, Key Competitors 18
Oriola-KD Oyj, Ratios based on current share price 19
Oriola-KD Oyj, Annual Ratios 20
Oriola-KD Oyj, Annual Ratios (Cont...1) 21
Oriola-KD Oyj, Annual Ratios (Cont...2) 22
Oriola-KD Oyj, Interim Ratios 24
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Oriola-KD Oyj, Recent Deals Summary 28
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46